All Stories

  1. Evaluation of Biocontrol Measures to Reduce Bacterial Load and Healthcare-Associated Infections

    Article • Microorganisms, August 2025, MDPI AG

    Donato Zipeto

  2. MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines

    Article • Non-Coding RNA, August 2025, MDPI AG

    Donato Zipeto

  3. Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression

    Article • Cells, February 2024, MDPI AG

    Donato Zipeto

  4. Advanced Cellular Models for Rare Disease Study: Exploring Neural, Muscle and Skeletal Organoids

    Article • International Journal of Molecular Sciences, January 2024, MDPI AG

    Donato Zipeto

  5. Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization

    Article • Vaccines, August 2023, MDPI AG

    Donato Zipeto

  6. Editorial: Nanomaterials for the diagnosis and therapy of viral infections

    Article • Frontiers in Bioengineering and Biotechnology, April 2023, Frontiers

    Donato Zipeto

  7. Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients

    Article • International Journal of Molecular Sciences, November 2022, MDPI AG

    Donato Zipeto

  8. Antibody response to BTN162b2 mRNA vaccination in naïve versus SARS-CoV-2 infected subjects with and without waning immunity

    Article • April 2021, Research Square

    Donato Zipeto

  9. Control of the Autophagy Pathway in Osteoarthritis: Key Regulators, Therapeutic Targets and Therapeutic Strategies

    Article • International Journal of Molecular Sciences, March 2021, MDPI AG

    Donato Zipeto

  10. SARS-CoV-2 Vaccination Elicits Unconventional IgM Specific Responses in Naïve and Previously COVID19-Infected Individuals

    Article • SSRN Electronic Journal, January 2021, Elsevier

    Professor Nigel James Temperton, Donato Zipeto

  11. Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?

    Article • Frontiers in Immunology, October 2020, Frontiers

    Donato Zipeto

  12. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19

    Article • Frontiers in Immunology, October 2020, Frontiers

    Donato Zipeto

  13. The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases

    Article • Genes, April 2020, MDPI AG

    Donato Zipeto

  14. Benzodiazepine Use and HIV-Associated Neurocognitive Impairment: Which Comes First?

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2020, Wolters Kluwer Health

    Donato Zipeto

  15. A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells

    Article • Cells, March 2020, MDPI AG

    Donato Zipeto

  16. Molecular and Lifestyle Factors Modulating Obesity Disease

    Article • Biomedicines, March 2020, MDPI AG

    Donato Zipeto

  17. NF-κB and MicroRNA Deregulation Mediated by HTLV-1 Tax and HBZ

    Article • Pathogens, December 2019, MDPI AG

    Donato Zipeto

  18. CRISPR/Cas system: An emerging technology in stem cell research

    Article • World Journal of Stem Cells, November 2019, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Donato Zipeto

  19. Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma

    Article • Heliyon, November 2019, Elsevier

    Donato Zipeto

  20. Physical Activity Prevents Cartilage Degradation: A Metabolomics Study Pinpoints the Involvement of Vitamin B6

    Article • Cells, November 2019, MDPI AG

    Donato Zipeto

  21. TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins

    Article • Frontiers in Microbiology, June 2019, Frontiers

    Donato Zipeto

  22. Runx2 stimulates neoangiogenesis through the Runt domain in melanoma

    Article • Scientific Reports, May 2019, Springer Science + Business Media

    Donato Zipeto

  23. Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player

    Article • Frontiers in Oncology, May 2019, Frontiers

    Donato Zipeto

  24. Inflammation in Cancer: Part of the Problem or Part of the Solution?

    Article • Journal of Immunology Research, February 2019, Hindawi Publishing Corporation

    Donato Zipeto, Iulia Popescu, Professor Monica Neagu

  25. RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3

    Article • The International Journal of Biochemistry & Cell Biology, January 2019, Elsevier

    Donato Zipeto

  26. HIV-1-Associated Neurocognitive Disorders: Is HLA-C Binding Stability to β2-Microglobulin a Missing Piece of the Pathogenetic Puzzle?

    Article • Frontiers in Neurology, September 2018, Frontiers

    Donato Zipeto

  27. Correction for Parolini et al., “Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity”

    Article • Journal of Virology, August 2018, ASM Journals

    Donato Zipeto

  28. Erratum: Corrigendum: HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity

    Article • Scientific Reports, May 2018, Springer Science + Business Media

    Donato Zipeto, Dr Agustin Valenzuela-Fernandez

  29. HTLV Deregulation of the NF-κB Pathway: An Update on Tax and Antisense Proteins Role

    Article • Frontiers in Microbiology, February 2018, Frontiers

    Donato Zipeto

  30. HLA-C stabiliy modulates HIV-1 infectivity

    Article • Journal of Virology, October 2017, ASM Journals

    Donato Zipeto

  31. IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia

    Article • Apmis, May 2017, Wiley

    Dr Ottavio Piccin, Donato Zipeto, Claudio Tripodo

  32. HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity

    Article • Scientific Reports, January 2017, Springer Science + Business Media

    Donato Zipeto, Dr Agustin Valenzuela-Fernandez

  33. Molecular characterization of HIV-1 Nef and ACOT8 interaction: insights from in silico structural predictions and in vitro functional assays

    Article • Scientific Reports, March 2016, Springer Science + Business Media

    Donato Zipeto

  34. Comment on "Influence of HLA-C Expression Level on HIV Control"

    Article • Science, September 2013, American Association for the Advancement of Science

    Donato Zipeto

  35. Gelsolin activity controls efficient early HIV-1 infection

    Article • Retrovirology, January 2013, Springer Science + Business Media

    Donato Zipeto, Dr Agustin Valenzuela-Fernandez

  36. HLA-C and HIV-1: friends or foes?

    Article • Retrovirology, May 2012, Springer Science + Business Media

    Donato Zipeto

  37. C3 HIV-1 Env and HLA-C

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2012, Wolters Kluwer Health

    Donato Zipeto

  38. 157a HLA-C Associates with Env and Increases HIV-1 Infectivity

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2011, Wolters Kluwer Health

    Donato Zipeto

  39. HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes

    Article • Journal of General Virology, September 2009, Society for General Microbiology

    Donato Zipeto

  40. Unsung Hero Robert C. Gallo

    Article • Science, January 2009, American Association for the Advancement of Science

    Dr Maria Lina Tornesello , Donato Zipeto, MD, PhD Roberto S Accolla

  41. Analysis of colorectal cancers for human cytomegalovirus presence

    Article • Infectious Agents and Cancer, January 2009, Springer Science + Business Media

    Donato Zipeto

  42. HLA-C increases HIV-1 infectivity and is associated with gp120

    Article • Retrovirology, January 2008, Springer Science + Business Media

    Donato Zipeto

  43. Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes

    Article • Microbes and Infection, May 2006, Elsevier

    Donato Zipeto

  44. Coinfection With HIV-1 and Human T-Cell Lymphotropic Virus Type II in Intravenous Drug Users Is Associated With Delayed Progression to AIDS

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2006, Wolters Kluwer Health

    Donato Zipeto

  45. New vaccine strategies for chronic viral infections

    Article • Drugs of the Future, January 2005, Thomson Reuters (Scientific) Inc. & Affiliates

    Donato Zipeto

  46. Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types.

    Article • Journal of General Virology, March 1999, Society for General Microbiology

    Donato Zipeto

  47. Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells

    Article • Journal of Experimental Medicine, September 1998, Rockefeller University Press

    Donato Zipeto

  48. Short Communication: Geographic and Demographic Differences in the Frequency of Human Cytomegalovirus gB Genotypes 1–4 in Immunocompromised Patients

    Article • AIDS Research and Human Retroviruses, April 1998, Mary Ann Liebert Inc

    Donato Zipeto

  49. Quantitation Of Human Cytomegalovirus DNA From Peripheral Blood Cells Of Human Immunodeficiency Virus-Infected Patients Could Predict Cytomegalovirus Retinitis

    Article • The Journal of Infectious Diseases, January 1995, Oxford University Press (OUP)

    Donato Zipeto

  50. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group.

    Article • Antimicrobial Agents and Chemotherapy, January 1994, ASM Journals

    Donato Zipeto

  51. Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction

    Article • Journal of Virological Methods, September 1993, Elsevier

    Donato Zipeto

  52. Identification of a human cytomegalovirus mutant in the pp150 matrix phosphoprotein gene with a growth-defective phenotype

    Article • Journal of General Virology, August 1993, Society for General Microbiology

    Donato Zipeto

  53. Human Cytomegalovirus Infection of the Major Leukocyte Subpopulations and Evidence for Initial Viral Replication in Polymorphonuclear Leukocytes from Viremic Patients

    Article • The Journal of Infectious Diseases, December 1992, Oxford University Press (OUP)

    Donato Zipeto

  54. Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leuckocytes from AIDS patients with human cytomegalovirus viraemia

    Article • Molecular and Cellular Probes, October 1991, Elsevier

    Donato Zipeto

  55. Monitoring of Human Cytomegalovirus Infections and Ganciclovir Treatment in Heart Transplant Recipients by Determination of Viremia, Antigenemia, and DNAemia

    Article • The Journal of Infectious Diseases, September 1991, Oxford University Press (OUP)

    Donato Zipeto